Fluphenazine Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Fluphenazine Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

WARNING

WARNINGS

FLUPHENAZINE HYDROCHLORIDE DESCRIPTION


Fluphenazine Hydrochloride



CLINICAL PHARMACOLOGY



INDICATIONS & USAGE




FLUPHENAZINE HYDROCHLORIDE CONTRAINDICATIONS



WARNINGS

Increased Mortality in Elderly Patients with Dementia-Related Psychosis
BOXED WARNING

Tardive Dyskinesia





PRECAUTIONS: Information for PatientsADVERSE REACTIONS: Tardive Dyskinesia

Neuroleptic Malignant Syndrome (NMS)









Usage in Pregnancy

Non-teratogenic Effects



Increased Mortality in Elderly Patients with Dementia-Related Psychosis
BOXED WARNING

Tardive Dyskinesia





PRECAUTIONS: Information for PatientsADVERSE REACTIONS: Tardive Dyskinesia

Neuroleptic Malignant Syndrome (NMS)









Usage in Pregnancy

Non-teratogenic Effects




PRECAUTIONS

Leukopenia, Neutropenia and Agranulocytosis



General







INFORMATION FOR PATIENTS



Abrupt Withdrawal




FLUPHENAZINE HYDROCHLORIDE ADVERSE REACTIONS

Central Nervous System



Extrapyramidal Symptoms

Dystonia

Class Effect


Tardive Dyskinesia
WARNINGS


Other CNS Effects
WARNINGS: Neuroleptic Malignant Syndrome (NMS)
Drowsiness or lethargy, if they occur, may necessitate a reduction in dosage; the induction of a catatonic-like state has been known to occur with dosages of fluphenazine far in excess of the recommended amounts. As with other phenothiazine compounds, reactivation or aggravation of psychotic processes may be encountered.
Phenothiazine derivatives have been known to cause, in some patients, restlessness, excitement, or bizarre dreams.

Autonomic Nervous System
Hypertension and fluctuations in blood pressure have been reported with fluphenazine hydrochloride.
Hypotension has rarely presented a problem with fluphenazine. However, patients with pheochromocytoma, cerebral vascular or renal insufficiency, or a severe cardiac reserve deficiency such as mitral insufficiency appear to be particularly prone to hypotensive reactions with phenothiazine compounds, and should therefore be observed closely when the drug is administered. If severe hypotension should occur, supportive measures including the use of intravenous vasopressor drugs should be instituted immediately. Norepinephrine bitartrate injection is the most suitable drug for this purpose; epinephrine should not be used since phenothiazine derivatives have been found to reverse its action, resulting in a further lowering of blood pressure.
Autonomic reactions including nausea and loss of appetite, salivation, polyuria, perspiration, dry mouth, headache, and constipation may occur. Autonomic effects can usually be controlled by reducing or temporarily discontinuing dosage.
In some patients, phenothiazine derivatives have caused blurred vision, glaucoma, bladder paralysis, fecal impaction, paralytic ileus, tachycardia, or nasal congestion.

Metabolic and Endocrine
Weight change, peripheral edema, abnormal lactation, gynecomastia, menstrual irregularities, false results on pregnancy tests, impotency in men and increased libido in women have all been known to occur in some patients on phenothiazine therapy.

Allergic Reactions
Skin disorders such as itching, erythema, urticaria, seborrhea, photosensitivity, eczema and even exfoliative dermatitis have been reported with phenothiazine derivatives. The possibility of anaphylactoid reactions occurring in some patients should be borne in mind.

Hematologic
Routine blood counts are advisable during therapy since blood dyscrasias including leukopenia, agranulocytosis, thrombocytopenic or non-thrombocytopenic purpura, eosinophilia, and pancytopenia have been observed with phenothiazine derivatives. Furthermore, if any soreness of the mouth, gums, or throat, or any symptoms of upper respiratory infection occur and confirmatory leukocyte count indicates cellular depression, therapy should be discontinued and other appropriate measures instituted immediately.

Hepatic


Others

Although this is not a general feature of fluphenazine, potentiation of central nervous system depressants (opiates, analgesics, antihistamines, barbiturates, alcohol) may occur.
The following adverse reactions have also occurred with phenothiazine derivatives: systemic lupus erythematosus-like syndrome, hypotension severe enough to cause fatal cardiac arrest, altered electrocardiographic and electroencephalographic tracings, altered cerebrospinal fluid proteins, cerebral edema, asthma, laryngeal edema, and angioneurotic edema; with long-term useskin pigmentation, and lenticular and corneal opacities.

DOSAGE & ADMINISTRATION







HOW SUPPLIED






























PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Fluphenazine Hydrochloride

Fluphenazine Hydrochloride

Fluphenazine Hydrochloride

Fluphenazine Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-279(NDC:0781-1437)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Fluphenazine Hydrochloride FLUPHENAZINE 2.5 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
D&C YELLOW NO. 10
FD&C BLUE NO. 2
FD&C YELLOW NO. 6
hydroxypropyl cellulose
HYPROMELLOSES
HYPROMELLOSE 2910 (3 MPA.S)
lactose monohydrate
MAGNESIUM STEARATE
polyethylene glycol
polysorbate 80
STARCH, CORN
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
orange 9 mm GG488 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-279-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA089584 2011-06-03


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.